Imprimed is a cutting-edge veterinary diagnostics company based in Palo Alto, CA. They specialize in providing accurate and personalized diagnostic support for canine and feline lymphoma and leukemia. Using advanced technologies such as flow cytometry and AI-driven drug response predictions, Imprimed helps veterinarians and pet owners make informed treatment decisions for their beloved pets. With a focus on efficiency and precision, Imprimed's services save time, money, and potentially improve treatment outcomes for dogs and cats with cancer.
By analyzing live cancer cells and combining this data with artificial intelligence, Imprimed offers a unique approach to cancer care for pets. Their comprehensive analysis allows for the identification of lymphoma or leukemia subtypes, detection of neoplastic B-cell or T-cell clones, and the identification of multidrug sensitivity genotyping. With a strong emphasis on personalized medicine, Imprimed's services provide pet owners with valuable insights and predictions that are specific to their individual animals, ultimately optimizing the chances of successful treatment outcomes.
Generated from the website